Team:UCSF/Parts
From 2010.igem.org
(Difference between revisions)
Line 242: | Line 242: | ||
<td>Stronger Signaling</td> | <td>Stronger Signaling</td> | ||
</tr> | </tr> | ||
- | + | <tr> | |
- | + | <td>Lianna</td> | |
- | + | ||
- | <tr | + | |
- | <td | + | |
<td>antiCD19CAR-OX40-CD3z</td> | <td>antiCD19CAR-OX40-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Carmen</td> |
<td>antiCD19CAR-SLAMF1-CD3z</td> | <td>antiCD19CAR-SLAMF1-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Carmen</td> |
<td>antiCD19CAR-SLAMF1-DAP10</td> | <td>antiCD19CAR-SLAMF1-DAP10</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Carmen</td> | |
- | <td | + | |
<td>antiCD19CAR-SLAMF5-DAP10</td> | <td>antiCD19CAR-SLAMF5-DAP10</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>John</td> |
- | + | ||
<td>antiMESOCAR-SLAMF1-CD3z</td> | <td>antiMESOCAR-SLAMF1-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>John</td> |
<td>antiMESOCAR-SLAMF5-DAP10</td> | <td>antiMESOCAR-SLAMF5-DAP10</td> | ||
- | + | <td>Stronger Signaling</td> | |
- | <td | + | |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Lianna</td> |
<td>antiCD19CAR-FcRg-STOP</td> | <td>antiCD19CAR-FcRg-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Lianna</td> |
<td>antiCD19CAR-ICOS-STOP</td> | <td>antiCD19CAR-ICOS-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Lianna</td> |
<td>antiCD19CAR-CD28-STOP</td> | <td>antiCD19CAR-CD28-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Lianna</td> |
<td>antiMESOCAR-FcRg-STOP</td> | <td>antiMESOCAR-FcRg-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Lianna</td> | |
- | <td | + | |
<td>antiMESOCAR-ICOS-STOP</td> | <td>antiMESOCAR-ICOS-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Lianna</td> |
- | + | ||
<td>antiMESOCAR-CD28-STOP</td> | <td>antiMESOCAR-CD28-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Lianna</td> |
<td>antiCD19CAR-LFA1-STOP</td> | <td>antiCD19CAR-LFA1-STOP</td> | ||
- | + | <td>Stronger Signaling</td> | |
- | <td | + | |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Lianna</td> |
<td>antiMESOCAR-LFA1-STOP</td> | <td>antiMESOCAR-LFA1-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td>antiCD19CAR-LFA1-CD3z</td> | <td>antiCD19CAR-LFA1-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td>antiMESOCAR-OX40-STOP</td> | <td>antiMESOCAR-OX40-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td>antiMESOCAR-SLAMF3-CD3z</td> | <td>antiMESOCAR-SLAMF3-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Crystal</td> | |
- | <td | + | |
<td>antiMESOCAR- CD3g-CD3z</td> | <td>antiMESOCAR- CD3g-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
- | + | ||
<td>antiMESOCAR-Ly49-STOP</td> | <td>antiMESOCAR-Ly49-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td>antiMESOCAR-NKG2A-STOP</td> | <td>antiMESOCAR-NKG2A-STOP</td> | ||
- | + | <td>Negative Feedback</td> | |
- | <td | + | |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td>antiCD19CAR-OX40-STOP</td> | <td>antiCD19CAR-OX40-STOP</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td>antiCD19CAR-SLAMF3-CD3z</td> | <td>antiCD19CAR-SLAMF3-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td> antiCD19CAR-CD3g-CD3z</td> | <td> antiCD19CAR-CD3g-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | <td | + | <td>Crystal</td> |
<td>antiCD19CAR-FcRg-CD3z</td> | <td>antiCD19CAR-FcRg-CD3z</td> | ||
- | <td | + | <td>Stronger Signaling</td> |
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMB-eGFP-CDMPR</td> | <td>GZMB-eGFP-CDMPR</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMB-eGFP-GILT</td> | <td>GZMB-eGFP-GILT</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMB-eGFP-LAMP</td> | <td>GZMB-eGFP-LAMP</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMB-eGFP-LIMP</td> | <td>GZMB-eGFP-LIMP</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMB-eGFP-Ymotif</td> | <td>GZMB-eGFP-Ymotif</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMB-eGFP-STP</td> | <td>GZMB-eGFP-STP</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMM-eGFP-CDMPR</td> | <td>GZMM-eGFP-CDMPR</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMM-eGFP-GILT</td> | <td>GZMM-eGFP-GILT</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMM-eGFP-LAMP</td> | <td>GZMM-eGFP-LAMP</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMM-eGFP-LIMP</td> | <td>GZMM-eGFP-LIMP</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMM-eGFP-Ymotif</td> | <td>GZMM-eGFP-Ymotif</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
- | <tr | + | <tr> |
- | + | <td>Min</td> | |
- | <td | + | |
<td>GZMM-eGFP-STP</td> | <td>GZMM-eGFP-STP</td> | ||
- | <td | + | <td>Localization to Cytoxic Granules </td> |
- | + | ||
- | + | ||
</tr> | </tr> | ||
</table> | </table> | ||
+ | |||
+ | |||
+ | <!-- content ends here --> | ||
</body> | </body> | ||
</html> | </html> | ||
- | |||
- | |||
{{Template:UCSF/WholeBlockEnd}} | {{Template:UCSF/WholeBlockEnd}} |
Revision as of 22:52, 27 October 2010
Parts
<groupparts>iGEM010 UCSF</groupparts>
Designed by | Ligated parts | Function | |
Carmen | Old antiMesoCAR-LFA1-Dap10 | Stronger Signaling | |
John | antiCD19CAR-DAP10-STOP | Positive Control | |
Hannah | antiCD19CAR-mDAP10y85F-STOP | Stronger Signaling | |
Lianna | antiCD19CAR-mDAP10N87Q-STOP | Negative Control | |
Sam | antiMESOCAR-mDAP10N87Q-STOP | Logic Gate Signaling | |
Crystal | antiMESOCAR-DAP10-CD3Z | Stronger Signaling | |
Crystal | antiMESOCAR- LFA1-CD3z | Stronger Signaling | |
Crystal | antiMESOCAR-DAP10-DAP10 | Stronger Signaling | |
Sam | antiCD19CAR-DAP10-CD3z | Stronger Signaling | |
Sam | antiCD19CAR-DAP10-Dap10 | Stronger Signaling | |
Sam | antiCD19CAR-CD3z-CD3z | Stronger Signaling | |
Carmen | antiMESOCAR-CD3Z-STOP | Positive Control | |
Carmen | antiCD19-CD3z-STOP | Stronger Signaling | |
Carmen | antiMESOCAR-KIR3DL2-STOP | Inhibition | |
Carmen | antiCD19CAR-KIR3DL2-STOP | Inhibition | |
Crystal | antiMESOCAR -LFA1 -DAP10 | Stronger Signaling | |
Crystal | antiMESOCAR-mDAP10 M88Q-STOP | Logic Gate Signaling | |
Crystal | antiCD19CAR-mDAP10 M88Q-STOP | Logic Gate Signaling | |
Lianna | antiMESOCAR-OX40-Dap10 | Stronger Signaling | |
Lianna | antiMESOCAR-OX40-CD3z | Stronger Signaling | |
Carmen | antiMESOCAR-FcRg-DAP10 | Stronger Signaling | |
Carmen | antiMESOCAR-ICOS-DAP10 | Stronger Signaling | |
Carmen | antiCD19CAR-FcRg-DAP10 | Stronger Signaling | |
Carmen | antiCD19CAR-ICOS-DAP10 | Stronger Signaling | |
Carmen | antiCD19CAR-LFA1-DAP10 | Stronger Signaling | |
Crystal | antiMESOCAR-CD3z-CD3z | Stronger Signaling | |
Lianna | antiMESOCAR-mDAP10Y85F-STOP | Logic Gate Negative Control | |
Connor | antiCD19CAR-KIR3DL1-STOP | Inhibition | |
Connor | antiMESOCAR-KIR3DL1-STOP | Inhibition | |
Crystal | antiMESOCAR-DAP10-STOP | Stronger Signaling | |
Lianna | antiCD19CAR-OX40-DAP10 | Stronger Signaling | |
Lianna | antiCD19CAR-OX40-CD3z | Stronger Signaling | |
Carmen | antiCD19CAR-SLAMF1-CD3z | Stronger Signaling | |
Carmen | antiCD19CAR-SLAMF1-DAP10 | Stronger Signaling | |
Carmen | antiCD19CAR-SLAMF5-DAP10 | Stronger Signaling | |
John | antiMESOCAR-SLAMF1-CD3z | Stronger Signaling | |
John | antiMESOCAR-SLAMF5-DAP10 | Stronger Signaling | |
Lianna | antiCD19CAR-FcRg-STOP | Stronger Signaling | |
Lianna | antiCD19CAR-ICOS-STOP | Stronger Signaling | |
Lianna | antiCD19CAR-CD28-STOP | Stronger Signaling | |
Lianna | antiMESOCAR-FcRg-STOP | Stronger Signaling | |
Lianna | antiMESOCAR-ICOS-STOP | Stronger Signaling | |
Lianna | antiMESOCAR-CD28-STOP | Stronger Signaling | |
Lianna | antiCD19CAR-LFA1-STOP | Stronger Signaling | |
Lianna | antiMESOCAR-LFA1-STOP | Stronger Signaling | |
Crystal | antiCD19CAR-LFA1-CD3z | Stronger Signaling | |
Crystal | antiMESOCAR-OX40-STOP | Stronger Signaling | |
Crystal | antiMESOCAR-SLAMF3-CD3z | Stronger Signaling | |
Crystal | antiMESOCAR- CD3g-CD3z | Stronger Signaling | |
Crystal | antiMESOCAR-Ly49-STOP | Stronger Signaling | |
Crystal | antiMESOCAR-NKG2A-STOP | Negative Feedback | |
Crystal | antiCD19CAR-OX40-STOP | Stronger Signaling | |
Crystal | antiCD19CAR-SLAMF3-CD3z | Stronger Signaling | |
Crystal | antiCD19CAR-CD3g-CD3z | Stronger Signaling | |
Crystal | antiCD19CAR-FcRg-CD3z | Stronger Signaling | |
Min | GZMB-eGFP-CDMPR | Localization to Cytoxic Granules | |
Min | GZMB-eGFP-GILT | Localization to Cytoxic Granules | |
Min | GZMB-eGFP-LAMP | Localization to Cytoxic Granules | |
Min | GZMB-eGFP-LIMP | Localization to Cytoxic Granules | |
Min | GZMB-eGFP-Ymotif | Localization to Cytoxic Granules | |
Min | GZMB-eGFP-STP | Localization to Cytoxic Granules | |
Min | GZMM-eGFP-CDMPR | Localization to Cytoxic Granules | |
Min | GZMM-eGFP-GILT | Localization to Cytoxic Granules | |
Min | GZMM-eGFP-LAMP | Localization to Cytoxic Granules | |
Min | GZMM-eGFP-LIMP | Localization to Cytoxic Granules | |
Min | GZMM-eGFP-Ymotif | Localization to Cytoxic Granules | |
Min | GZMM-eGFP-STP | Localization to Cytoxic Granules |